{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:10:13Z","timestamp":1740017413503,"version":"3.37.3"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1124\/jpet.109.154583","type":"journal-article","created":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T02:39:34Z","timestamp":1246415974000},"page":"771-782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cross-Talk between Protein Kinase A and Mitogen-Activated Protein Kinases Signalling in the Adaptive Changes Observed during Morphine Withdrawal in the Heart"],"prefix":"10.1016","volume":"330","author":[{"given":"P.","family":"Almela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.M.","family":"Atucha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.V.","family":"Milan\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.L.","family":"Laorden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.109.154583_bib1","doi-asserted-by":"crossref","unstructured":"Almela P, Cerezo M, Gonz\u00e1lez-Cuello A, Milan\u00e9s MV, and Laorden ML (2007a) Differential involvement of 3\u2032,5\u2032-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos and tyrosine hydroxylase expression in the heart after naloxone induced morphine withdrawal. Naunyn Schmiedebergs Arch Pharmacol 374: 293-303.","DOI":"10.1007\/s00210-006-0120-z"},{"key":"10.1124\/jpet.109.154583_bib2","doi-asserted-by":"crossref","unstructured":"Almela P, Milan\u00e9s MV, and Laorden ML (2007b) Activation of ERK signalling pathway contributes to the adaptive changes in rat hearts during naloxone-induced morphine withdrawal. Br J Pharmacol 151: 787-797.","DOI":"10.1038\/sj.bjp.0707301"},{"key":"10.1124\/jpet.109.154583_bib3","doi-asserted-by":"crossref","unstructured":"Almela P, Milan\u00e9s M, and Laorden M (2008) The PKs PKA and ERK 1\/2 are involved in phosphorylation of TH at serine 40 and 31 during morphine withdrawal in rat hearts. Br J Pharmacol 155: 73-83.","DOI":"10.1038\/bjp.2008.224"},{"key":"10.1124\/jpet.109.154583_bib4","doi-asserted-by":"crossref","unstructured":"Atkins CM, Selcher JC, Petraitis JJ, Trzaskos JM, and Sweatt JD (1998) The MAPK cascade is required for mammalian associative learning. Nat Neurosci 1: 602-609.","DOI":"10.1038\/2836"},{"key":"10.1124\/jpet.109.154583_bib5","doi-asserted-by":"crossref","unstructured":"Cerezo M, Milan\u00e9s MV, and Laorden ML (2005) Alterations in protein kinase A and different protein kinase C isoforms in the heart during morphine withdrawal. Eur J Pharmacol 522: 9-19.","DOI":"10.1016\/j.ejphar.2005.08.025"},{"key":"10.1124\/jpet.109.154583_bib6","doi-asserted-by":"crossref","unstructured":"Childers SR (1991) Opioid receptor-coupled second messengers systems. Life Sci 48: 1991-2003.","DOI":"10.1016\/0024-3205(91)90154-4"},{"key":"10.1124\/jpet.109.154583_bib7","doi-asserted-by":"crossref","unstructured":"Dunkley PR, Bobrovskaya L, Graham ME, von Nagy-Felsobuki EI, and Dickson PW (2004) Tyrosine hydroxylase phosphorylation: regulation and consequences. J Neurochem 91: 1025-1043.","DOI":"10.1111\/j.1471-4159.2004.02797.x"},{"key":"10.1124\/jpet.109.154583_bib8","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Cuello A, Milan\u00e9s MV, Castells MT, and Laorden ML (2003) Activation c-Fos expression in the heart after morphine but not U-50, 488H withdrawal. Br J Pharmacol 138: 626-633.","DOI":"10.1038\/sj.bjp.0705093"},{"key":"10.1124\/jpet.109.154583_bib9","doi-asserted-by":"crossref","unstructured":"Gross ER, Hsu AK, and Gross GJ (2007) GS\u03b2 inhibition and KATP channel opening mediate acute opioid-induced cardioprotection at reperfusion. Basic Res Cardiol 102: 341-349.","DOI":"10.1007\/s00395-007-0651-6"},{"key":"10.1124\/jpet.109.154583_bib10","doi-asserted-by":"crossref","unstructured":"Haycock JW, Ahn NG, Cobbe MH, and Krebs EG (1992) ERK 1 and ERK 2, Two Microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at serine-31 in situ. Proc Natl Acad Sci U S A 89: 2365-2369.","DOI":"10.1073\/pnas.89.6.2365"},{"key":"10.1124\/jpet.109.154583_bib11","doi-asserted-by":"crossref","unstructured":"Hidaka H, Inagaki M, Kawamoto S, and Sasaki Y (1984) Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23: 5036-5041.","DOI":"10.1021\/bi00316a032"},{"key":"10.1124\/jpet.109.154583_bib12","doi-asserted-by":"crossref","unstructured":"Hussain M, Drago GA, Bhogal M, Colyer J, and Orchard CH (1999) Effects of the protein kinase A inhibitor H-89 on Ca2+ regulation in isolated ferret ventricular myocytes. Pflugers Arch 437: 529-537.","DOI":"10.1007\/s004240050814"},{"key":"10.1124\/jpet.109.154583_bib13","doi-asserted-by":"crossref","unstructured":"Impey S, Obrietan K, Wong ST, Poser S, Yano S, Wayman G, Deloulme JC, Chan G, and Storm DR (1998) Crosstalk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation. Neuron 21: 869-883.","DOI":"10.1016\/S0896-6273(00)80602-9"},{"key":"10.1124\/jpet.109.154583_bib14","doi-asserted-by":"crossref","unstructured":"Kamp TJ and Hell JW (2000) Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ Res 87: 1095-1102.","DOI":"10.1161\/01.RES.87.12.1095"},{"key":"10.1124\/jpet.109.154583_bib15","doi-asserted-by":"crossref","unstructured":"Kao YS and Fong JC (2008) Endothelin-1 induction of Glut1 transcription in 3T-L1 adipocytes involves distinct PKC\u03f5- and p42\/44 MAPK-dependent pathways. Biochem Biophys Acta 1780: 154-159.","DOI":"10.1016\/j.bbagen.2007.11.013"},{"key":"10.1124\/jpet.109.154583_bib16","doi-asserted-by":"crossref","unstructured":"Kienbaum P, Heuter T, Michel MC, Scherbaum N, Gastpar M, and Peters J (2001) Chronic \u03bc-opioid receptor stimulation in humans decreases muscle sympathetic nerve activity. Circulation 103: 850-855.","DOI":"10.1161\/01.CIR.103.6.850"},{"key":"10.1124\/jpet.109.154583_bib17","doi-asserted-by":"crossref","unstructured":"Kienbaum P, Heuter T, Scherbaum N, Gastpar M, and Peters J (2002) Chronic \u03bc-opioid receptor stimulation alters cardiovascular regulation in humans: differential effects on muscle sympathetic and heart rate responses to arterial hypotension. J Cardiovasc Pharmacol 40: 363-369.","DOI":"10.1097\/00005344-200209000-00005"},{"key":"10.1124\/jpet.109.154583_bib18","doi-asserted-by":"crossref","unstructured":"Kobayashi E, Nakano H, Morimoto M, and Tamaoki T (1989) Calphostin C (UCN), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 159: 548-553.","DOI":"10.1016\/0006-291X(89)90028-4"},{"key":"10.1124\/jpet.109.154583_bib19","doi-asserted-by":"crossref","unstructured":"Laorden ML, Fuertes G, Gonz\u00e1lez-Cuello A, and Milan\u00e9s MV (2000) Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of A1 and A2 adrenoceptors. J Pharmacol Exp Ther 293: 578-584.","DOI":"10.1016\/S0022-3565(24)39271-7"},{"key":"10.1124\/jpet.109.154583_bib20","doi-asserted-by":"crossref","unstructured":"Lindgren N, Goiny M, Herrera-Marschitz M, Haycock JW, H\u00f6kfelt T, and Fisone G (2002) Activation of extracellular signal-regulated kinases 1 and 2 by depolarization stimulates tyrosine hydroxylase phosphorylation and dopamine synthesis in rat brain. Eur J Neurosci 15: 769-773.","DOI":"10.1046\/j.1460-9568.2002.01901.x"},{"key":"10.1124\/jpet.109.154583_bib21","doi-asserted-by":"crossref","unstructured":"Michel MC, Li Y, and Heusch G (2001) Mitogen-activated protein kinases in the heart. Naunyn Schmiedebergs Arch Pharmacol 363: 245-266.","DOI":"10.1007\/s002100000363"},{"key":"10.1124\/jpet.109.154583_bib22","doi-asserted-by":"crossref","unstructured":"Milan\u00e9s MV, Fuente T, Mar\u00edn MT, and Laorden ML (1999) Catecholaminergic activity and 3\u2032,5\u2032-cyclic adenosine monophosphate concentrations in the right ventricle after acute and chronic morphine administration in the rat. Br J Anaesth 83: 784-788.","DOI":"10.1093\/bja\/83.5.784"},{"key":"10.1124\/jpet.109.154583_bib23","doi-asserted-by":"crossref","unstructured":"Milan\u00e9s MV, Fuente T, and Laorden ML (2000) Catecholaminergic activity and 3\u2032,5\u2032-cyclic adenosine monophosphate levels in heart right ventricle after naloxone induced withdrawal. Naunyn Schmiedebergs Arch Pharmacol 361: 61-66.","DOI":"10.1007\/s002109900165"},{"key":"10.1124\/jpet.109.154583_bib24","doi-asserted-by":"crossref","unstructured":"Nestler EJ and Aghajanian GK (1997) Molecular and cellular basis of addiction. Science 278: 58-63.","DOI":"10.1126\/science.278.5335.58"},{"key":"10.1124\/jpet.109.154583_bib25","doi-asserted-by":"crossref","unstructured":"Obara Y, Horgan AM, and Stork PJ (2007) The requirement of Ras and Rap1 for the activation of ERKs by cAMP, PACAP, and KCL in cerebellar granule cells. J Neurochem 101: 470-482.","DOI":"10.1111\/j.1471-4159.2006.04390.x"},{"key":"10.1124\/jpet.109.154583_bib26","doi-asserted-by":"crossref","unstructured":"Peart JN and Gross GJ (2006) Cardioprotective effects of acute and chronic opioid treatment is mediated via different signalling pathways. Am J Physiol Heart Circ Physiol 291: H1746-H1753.","DOI":"10.1152\/ajpheart.00233.2006"},{"key":"10.1124\/jpet.109.154583_bib27","doi-asserted-by":"crossref","unstructured":"Peart JN, Gross ER, Reichelt ME, Hsu A, Headrick JP, and Gross GJ (2008) Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts. Basic Res Cardiol 103: 454-463.","DOI":"10.1007\/s00395-008-0726-z"},{"key":"10.1124\/jpet.109.154583_bib28","doi-asserted-by":"crossref","unstructured":"Pozzi L, H\u00e5kansson K, Usiello A, Borgkvist A, Lindskog M, Greengard P, and Fisone G (2003) Opposite regulation by typical and atypical anti-psychotics of ERK1\/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum. J Neurochem 86: 451-459.","DOI":"10.1046\/j.1471-4159.2003.01851.x"},{"key":"10.1124\/jpet.109.154583_bib29","doi-asserted-by":"crossref","unstructured":"Pugsley MK (2002) The diverse molecular mechanism responsible for the actions of opioids on the cardiovascular system. Pharmacol Ther 93: 51-75.","DOI":"10.1016\/S0163-7258(02)00165-1"},{"key":"10.1124\/jpet.109.154583_bib30","doi-asserted-by":"crossref","unstructured":"Rabad\u00e1n JV, Milan\u00e9s MV, and Laorden ML (1997) Effects of chronic morphine treatment on catecholamines content and mechanical response in the rat heart. J Pharmacol Exp Ther 280: 32-37.","DOI":"10.1016\/S0022-3565(24)36364-5"},{"key":"10.1124\/jpet.109.154583_bib31","doi-asserted-by":"crossref","unstructured":"Rabad\u00e1n JV, Milan\u00e9s MV, and Laorden ML (1998) Changes in right atrial catecholamine content in na\u00efve rats and after naloxone-induced withdrawal. Br J Anaesth 80: 354-359.","DOI":"10.1093\/bja\/80.3.354"},{"key":"10.1124\/jpet.109.154583_bib32","doi-asserted-by":"crossref","unstructured":"Ren X, Noda Y, Mamiya T, Nagai T, and Nabeshima TA (2004) Neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-Fos expression linked to the extracellular signal-regulated protein kinase. Behav Brain Res 152: 243-250.","DOI":"10.1016\/j.bbr.2003.10.013"},{"key":"10.1124\/jpet.109.154583_bib33","doi-asserted-by":"crossref","unstructured":"Sengupta N, Vinod PK, and Venkatesh KV (2007) Crosstalk between cAMP\/PKA and MAP kinase pathways is a key regulatory design necessary to regulate FLO11 expression. Biophys Chem 125: 59-71.","DOI":"10.1016\/j.bpc.2006.06.012"},{"key":"10.1124\/jpet.109.154583_bib34","doi-asserted-by":"crossref","unstructured":"Sindreu CB, Scheiner ZS, and Storm DR (2007) Ca2+-stimulated adenylyl cyclases regulate ERK-dependent activation of MSK1 during fear conditioning. Neuron 53: 79-89.","DOI":"10.1016\/j.neuron.2006.11.024"},{"key":"10.1124\/jpet.109.154583_bib35","doi-asserted-by":"crossref","unstructured":"Stork PJ and Schmitt JM (2002) Crosstalk between cAMP and MAP kinase signalling in the regulation of cell proliferation. Trends Cell Biol 12: 258-266.","DOI":"10.1016\/S0962-8924(02)02294-8"},{"key":"10.1124\/jpet.109.154583_bib36","doi-asserted-by":"crossref","unstructured":"Sugden PH and Bogoyevitch MA (1995) Intracellular signalling through protein kinases in the heart. Cardiovasc Res 30: 478-492.","DOI":"10.1016\/S0008-6363(95)00096-8"},{"key":"10.1124\/jpet.109.154583_bib37","doi-asserted-by":"crossref","unstructured":"Ueda H (2004) Locus-specific involvements of anti-opioid systems in morphine tolerance and dependence. Ann N Y Acad Sci 1025: 376-382.","DOI":"10.1196\/annals.1307.046"},{"key":"10.1124\/jpet.109.154583_bib38","doi-asserted-by":"crossref","unstructured":"Villalba M, Bockaert J, and Journot L (1997) Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway. J Neurosci 17: 83-90.","DOI":"10.1523\/JNEUROSCI.17-01-00083.1997"},{"key":"10.1124\/jpet.109.154583_bib39","doi-asserted-by":"crossref","unstructured":"Vossler MR, Yao H, York RD, Pan MG, Rim CS, and Stork PJ (1997) cAMP activates MAP kinase and Elk-1 trough a B-Raf and Rap-1-dependent pathway. Cell 89: 73-82.","DOI":"10.1016\/S0092-8674(00)80184-1"},{"key":"10.1124\/jpet.109.154583_bib40","doi-asserted-by":"crossref","unstructured":"Wiechelman KJ, Braun RD, and Fitzpatrick JD (1988) Investigation of the bicinchoninic acid protein assay: identification of the groups responsible for colour formation. Anal Biochem 175: 231-237.","DOI":"10.1016\/0003-2697(88)90383-1"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524385751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524385751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.109.154583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T01:35:26Z","timestamp":1740015326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524385751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0022356524385751"],"URL":"https:\/\/doi.org\/10.1124\/jpet.109.154583","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-Talk between Protein Kinase A and Mitogen-Activated Protein Kinases Signalling in the Adaptive Changes Observed during Morphine Withdrawal in the Heart","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.109.154583","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}